TEL (24 hours hotline) +86 166 0110 4668

Home >>  About Us >> News & Event >> Industry News

The "Belt and Road" Initiative to Draw a New Blueprint for Modern Anesthesia Development

Nov. 18, 2025

         Recently, at the opening ceremony of the Indonesian Anesthesiologists' Annual Conference, the Chinese Society

 of Anesthesiology and the Indonesian Society of Anesthesiology and Intensive Therapy engaged in in-depth dialogue, 

holding enthusiastic discussions on the clinical application of anesthetic drugs like Remifentanil. This marks a new 

phase of cooperation between China and Indonesia in the field of perioperative medicine.


          The "Belt and Road" Initiative to Draw a New Blueprint for Modern Anesthesia Development


         As a professional manufacturer of anesthesia machines, Dolphinmed consistently supports and responds to the

 national "Belt and Road" Initiative, actively advancing the modernization and intelligent development of anesthesia 

equipment. We deeply understand that the high-quality development of anesthesiology relies on advanced equipment 

support and continuous clinical practice innovation.


          The "Belt and Road" Initiative to Draw a New Blueprint for Modern Anesthesia Development


         During this academic exchange, Chinese experts shared practical experience with Remifentanil in clinical anesthesia 

in China, showcasing China's achievements in the refined application of anesthetic drugs. Dolphinmed is always

 committed to providing robust support for perioperative safety management through its high-performance and reliable

 anesthesia machine products, promoting the implementation of "new practices" in anesthesia.


         In the future,Dolphinmed will continue to collaborate with the domestic and international anesthesiology community,

 empowering anesthesia through technology and promoting win-win outcomes through cooperation. Together, we will

 drive the overall improvement of anesthesia standards in countries along the "Belt and Road," contributing the strength 

of Chinese manufacturing to the cause of global health.